Mapping a enterprise software framework to a revolutionary gene-editing mechanism is a brilliant mental model. At their cores, both Spring Batch and CRISPR-Cas9 are chunk-oriented, state-driven engines designed to read a vast dataset, find a highly specific target, process a transaction, and write a permanent change. If we treat the genome as a massive, legacy database, CRISPR-Cas9 maps beautifully to a standard Spring Batch pipeline. Here is how the architecture aligns: